​

Funding Round

Series F - RareCyte

Series F - RareCyte

Investment Firm

Overview

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Announced Date

Dec 19, 2019

Funding Type

Series F

Highlights

Location

United States, North America

Social

Investor Lead

HealthQuest Capital

HealthQuest Capital

HealthQuest Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and venture firm.

Participant Investors

2

Investor Name
Participant Investor5AM Ventures
Participant InvestorHealthQuest Capital

Round Details and Background

RareCyte raised $22000000 on 2019-12-19 in Series F

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 03, 2022
Grant - RareCyte
1-undefined
Jun 27, 2024
Venture Round - RareCyte
9-20.0M
Aug 29, 2017
Venture Round - RareCyte
3-30.0M
Aug 21, 2012
Venture Round - RareCyte
1-undefined

Recent Activity

There is no recent news or activity for this profile.